Kidney Cancer

Two-Drug Combo Superior to Sunitinib as First-Line Therapy for Advanced RCC

By

Jody A. Charnow

Publish Date September 25, 2020

Compared with sunitinib alone, nivolumab plus cabozantinib therapy was associated with a 49% decreased risk for progression and 40% decreased risk for death.

Immunotherapy Plus Radiotherapy After Surgery Improves OS in Tumors With Brain Metastases, Study Finds

By

Rick Maffei

Publish Date September 23, 2020

Study found adding immunotherapy to radiotherapy significantly improved OS after definitive surgery for primary tumor in patients with brain metastasis.

Immunotherapy Improves Survival Despite Brain Metastases

By

Jody A. Charnow

Publish Date September 17, 2020

Immunotherapy improved median overall survival by 7.5 months regardless of what other treatments patients received.

Metastasectomy Survival Benefit in mRCC Cases Confirmed

By

Jody A. Charnow

Publish Date September 7, 2020

New data show that complete metastasectomy for selected cases of metastatic renal cell carcinoma (mRCC) prolongs survival in the postcytokine therapy era.

Complete Metastasectomy Found to Prolong Survival in mRCC

By

Natasha Persaud

Publish Date August 25, 2020

A study showed that mortality risk was reduced by 59% for patients who underwent complete metastasectomy compared with those who did not.